Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Health Catalyst Inc’s current trading price is -46.75% away from its 52-week high, while its distance from the 52-week low is 3.19%. The stock’s price range during this period has varied between $5.32 and $10.31. The company, active in the Healthcare sector, saw a trading volume of around 0.72 million for the day, considerably higher average daily volume of 0.65 million observed over the last three months.
Health Catalyst Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $10.31 on 02/12/24, and the lowest price during the same period was recorded at $5.32 on 02/03/25.
How Financial Performance Impacts Market Capitalization
Health Catalyst Inc (HCAT) has experienced a quarterly decline of -28.52% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 334.05M and boasts a workforce of 1300 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.57, with a change in price of -2.53. Similarly, Health Catalyst Inc recorded 584,907 in trading volume during the last 100 days, posting a change of -31.55%.
How HCAT’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for HCAT stands at 1.03. Similarly, the long-term debt-to-equity ratio is also 0.37.
HCAT Stock Stochastic Average
As of today, the raw stochastic average of Health Catalyst Inc over the past 50 days is 4.33%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 8.03%. Additionally, the Stochastic %K and %D values for the company were 15.46% and 13.63%, respectively, over the past 20 days.
HCAT Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -22.35%.However, over the last six months, we can see a stronger performance of -7.42%. Over the last 30 days, the price of HCAT has leaped by -25.81%. And in the last five days, it has fallen by -0.54%.
